A Phase III clinical trial found that nicotinamide riboside, an NAD-boosting supplement, did not slow Parkinson’s disease.

Simultaneously reprogramming immune cells and strengthening T cells can make glioblastoma tumors shrink and prevent ...

A study of nearly 40,000 patients suggests germline testing should be offered more broadly to adults diagnosed with solid ...

HPV vaccination before pregnancy lowers the risk of major birth complications, offering benefits beyond reducing the risk of ...

An optogenetic therapy has shown early evidence of improved visual function, with no safety concerns, in patients with advanced retinitis pigmentosa.

Researchers have identified a previously unrecognized protective role for the brain’s immune cells in people with Parkinson’s disease.

The mechanism behind an experimental cancer drug that shows potential for treating glioblastoma is not what researchers initially expected.

Chemotherapy could make cancer vaccines more effective, and adding PD-1 blockade to the mix could be even better, according to new research from the Oxford Branch of the Ludwig Institute for Cancer ...

A single tRNA can influence whether prostate cancer cells mutate and become difficult to treat with standard therapies.

Standardized patient-derived glioblastoma organoids mirrored patients' radiotherapy responses and showed BET inhibitors may overcome radiation resistance.

Nuclear localization of fumarylacetoacetate hydrolase is associated with CDK4/6 inhibitor resistance in hormone receptor ...

An analysis of multiple cancer types has revealed mitochondrial DNA copy number as a key determinant of mutational load and ...